Iloperidone set to take on schizophrenia

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1634, 2008-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Iloperidone for schizophrenia

By Rado Jeffrey Janicak Philip G

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2087-2093

Informa Healthcare

Access to resources Recommend Favorite

Iloperidone: In Schizophrenia

By Scott Lesley J.

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 867-880

Adis International

Access to resources Recommend Favorite

Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial

By Lavedan Christian Volpi Simona Polymeropoulos Mihael H Wolfgang Curt D

Pharmacogenomics, Vol. 9, Iss. 3, 2008-03 ,pp. : 289-301

Future Medicine

Access to resources Recommend Favorite

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder: A Systematic Review and Exploratory Meta-Analysis

By > Yu Weiping Detraux Johan Sweers Kim > Correll Christoph U.

CNS Drugs, Vol. 26, Iss. 9, 2012-09 ,pp. : 733-759

Adis International

Access to resources Recommend Favorite

French price cuts set to take effect

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 282, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite